ATE80895T1 - Bordetella pertussis-polypeptide und toxinantigene. - Google Patents

Bordetella pertussis-polypeptide und toxinantigene.

Info

Publication number
ATE80895T1
ATE80895T1 AT87850312T AT87850312T ATE80895T1 AT E80895 T1 ATE80895 T1 AT E80895T1 AT 87850312 T AT87850312 T AT 87850312T AT 87850312 T AT87850312 T AT 87850312T AT E80895 T1 ATE80895 T1 AT E80895T1
Authority
AT
Austria
Prior art keywords
arg
thr
glu
tyr
val
Prior art date
Application number
AT87850312T
Other languages
English (en)
Inventor
Tamas Bartfai
Original Assignee
Trion Forskning & Utveckling
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trion Forskning & Utveckling filed Critical Trion Forskning & Utveckling
Application granted granted Critical
Publication of ATE80895T1 publication Critical patent/ATE80895T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT87850312T 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene. ATE80895T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8604445A SE455946B (sv) 1986-10-20 1986-10-20 Nya pertussistoxin-polypeptider och antigener samt testsatser, vacciner och intradermala hudtestkompositioner
EP87850312A EP0266325B1 (de) 1986-10-20 1987-10-19 Bordetella Pertussis-Polypeptide und Toxinantigene

Publications (1)

Publication Number Publication Date
ATE80895T1 true ATE80895T1 (de) 1992-10-15

Family

ID=20365987

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87850312T ATE80895T1 (de) 1986-10-20 1987-10-19 Bordetella pertussis-polypeptide und toxinantigene.

Country Status (12)

Country Link
US (1) US5225193A (de)
EP (1) EP0266325B1 (de)
JP (1) JP2635641B2 (de)
AT (1) ATE80895T1 (de)
AU (1) AU624066B2 (de)
DE (1) DE3781863T2 (de)
DK (1) DK312088A (de)
FI (1) FI891872A0 (de)
IE (1) IE872802L (de)
PT (1) PT85960B (de)
SE (1) SE455946B (de)
WO (1) WO1988002754A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine
IT1229766B (it) * 1989-05-19 1991-09-10 Sclavo Spa Peptidi sintetici capaci di stimolare una immunita' t cellulare.
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
DE4430601A1 (de) * 1994-08-22 1996-02-29 Beiersdorf Ag Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander
US10864213B2 (en) 2014-05-12 2020-12-15 Verona Pharma Plc Treatment

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質
JPS5767591A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein element substance and its preparation
JPS5767592A (en) * 1980-10-11 1982-04-24 Kaken Pharmaceut Co Ltd Protein having reassociating properties and its preparation
JPS58222032A (ja) * 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
WO1988004665A1 (en) * 1986-12-22 1988-06-30 Trion Forskning- Och Utvecklings Aktiebolag A new pertussis toxin derived polypeptide and applications thereof
AU614755B2 (en) * 1987-06-05 1991-09-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Autocrine motility factors in cancer diagnosis and management
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine

Also Published As

Publication number Publication date
SE8604445D0 (sv) 1986-10-20
IE872802L (en) 1988-04-20
PT85960A (en) 1987-11-01
FI891872A (fi) 1989-04-19
AU8152487A (en) 1988-05-06
EP0266325B1 (de) 1992-09-23
US5225193A (en) 1993-07-06
PT85960B (pt) 1990-07-31
DE3781863D1 (de) 1992-10-29
FI891872A0 (fi) 1989-04-19
JPH02500977A (ja) 1990-04-05
SE455946B (sv) 1988-08-22
JP2635641B2 (ja) 1997-07-30
WO1988002754A1 (en) 1988-04-21
DK312088D0 (da) 1988-06-08
DE3781863T2 (de) 1993-03-11
DK312088A (da) 1988-08-10
SE8604445L (sv) 1988-04-21
AU624066B2 (en) 1992-06-04
EP0266325A1 (de) 1988-05-04

Similar Documents

Publication Publication Date Title
SE8704185L (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
DE3688246T2 (de) Kunstpolypeptide zum nachweis mykobakterieller infektionen.
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
Child et al. A review of the applications of immunochemistry to archaeological bone
ATE80895T1 (de) Bordetella pertussis-polypeptide und toxinantigene.
Gerencser et al. Serological identification of Actinomyces using fluorescent antibody techniques
DK0425082T3 (da) Vacciner
DE69034254D1 (de) A-pdgf-rezeptor und dessen verwendung
ATE94880T1 (de) Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung.
DK232988D0 (da) Fremgangsmaade til immunologisk bestemmelse af aminoterminalt prokollagen peptidtype iii og antistoffer til gennemfoerelse heraf.
Foster et al. Serological and cellular immune responses to non‐structural proteins in animals infected with FMDV
ES2080955T3 (es) Anticuerpos especificos de la pancreaelastasa 1, procedimiento para su obtencion y equipo de analisis que contiene este tipo de anticuerpos.
DE69026875T2 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
Wiertz et al. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans
SE8901566D0 (sv) Nya peptider inkluderande en disulfidbindning
KR910005887A (ko) 면역원성 물질의 고-보존된 아미노산 서열에 대한 항체, 이의 항체의 제조 방법 및 면역 감정에서의 이의 용도
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
JPS6490197A (en) Peptide
Ohman Jr et al. Physiochemical and biologic properties of allergen extracted from cat pelts
ATE88639T1 (de) Antigenisches peptid der 28kd proteingruppe aus s. mansoni und sein verfahren zur isolierung, monoklonale antikoerper, die mindestens ein epitop dieses peptids erkennen und verwendungen fuer die induzierung der synthese von neutralisierenden antikoerpern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties